Cizumab 100 mg

Cizumab is a prescription medication used to treat certain types of cancer, including:

Colorectal cancer (a type of cancer that affects the colon and rectum)
Lung cancer (a type of cancer that affects the lungs)
Brain cancer (a type of cancer that affects the brain)
Kidney cancer (a type of cancer that affects the kidneys)

Composition:

Cizumab is a clear, colorless solution containing 100mg of bevacizumab per milliliter.

Mechanism of Action:

Bevacizumab works by:

Blocking the growth of new blood vessels that feed cancer cells
Reducing the ability of cancer cells to spread to other parts of the body

Uses:

Cizumab is used to treat:

Colorectal cancer (a type of cancer that affects the colon and rectum)
Lung cancer (a type of cancer that affects the lungs)
Brain cancer (a type of cancer that affects the brain)
Kidney cancer (a type of cancer that affects the kidneys)

Dosage:

The recommended dosage of Cizumab is:

10mg/kg body weight administered intravenously over 30-90 minutes
Repeat every 2-3 weeks, depending on the patient’s response to treatment

Side Effects:

Common side effects of Cizumab include:

High blood pressure
Headache
Fatigue
Nausea and vomiting
Diarrhea
Increased risk of infection
Increased risk of bleeding
Hair loss
Skin rash

Recommendation:

Cizumab is recommended for patients with certain types of cancer who have not responded to other treatments. Patients should also be advised to monitor their blood pressure and liver function regularly during treatment.

Important Note:

Patients should not take Cizumab if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Cizumab.

Some common brands of bevacizumab include: